Antifibrotic treatment in 18 patients with chronic Hypersensitivity Pneumonitis

V. Tzilas (Athens, Greece), A. Tzouvelekis (Athens, Greece), E. Bouros (Athens, Greece), M. Katsaras (Athens, Greece), M. Ntassiou (Athens, Greece), T. Karampitsakos (Athens, Greece), D. Bouros (Athens, Greece)

Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases
Session: Assessment and management of immune-mediated interstitial lung diseases
Session type: Thematic Poster
Number: 4733
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Tzilas (Athens, Greece), A. Tzouvelekis (Athens, Greece), E. Bouros (Athens, Greece), M. Katsaras (Athens, Greece), M. Ntassiou (Athens, Greece), T. Karampitsakos (Athens, Greece), D. Bouros (Athens, Greece). Antifibrotic treatment in 18 patients with chronic Hypersensitivity Pneumonitis. 4733

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: